Duplessis Christopher A, Gutierrez Ramiro L, Porter Chad K
Enteric Disease Department, Infectious Disease Directorate, Naval Medical Research Center, 503 Robert Grant Avenue, Silver Spring, MD 20910 USA.
Trop Dis Travel Med Vaccines. 2017 May 4;3:9. doi: 10.1186/s40794-017-0052-2. eCollection 2017.
Travelers' diarrhea is a common malady afflicting up to 50% of travelers after a 2-week travel period. An appreciable percentage of these cases will become persistent or chronic. We summarized the published literature reporting persistent/chronic diarrhea in travelers elucidating current understanding of disease incidence, etiology and regional variability.
We searched electronic databases (Medline, Embase, and Cochrane database of clinical trials) from 1990 to 2015 using the following terms: "chronic or persistent diarrh* and (returning) travel* or enteropathogen, GeoSentinel, and travel-associated infection. Included studies published in the English language on adult returning travelers (duration < 3-months) reporting denominator data. Point estimates and standard 95% confidence intervals were calculated for incidence using a random-effects model. Study incidence heterogeneity rates were assessed using heterogeneity statistics, graphically represented with Forest plots.
We identified 19 studies meeting the inclusion criteria (all published after 1999). 18 studies reported upon the incidence of persistent/chronic diarrhea as a syndromic diagnosis in returning travelers; one study reported adequate denominator data from which to assess pathogen specific etiology. comprise an appreicaible percentage of infectious mediated persistent/chronic diarrhea in returning travelers. The overall estimate of persistent/chronic diarrhea incidence was 6% (0.05-0.07) in 321,454, travelers; with significant heterogeniety observed across regions. The total number of regional travelers, and point estimates for incidence (95% CI) for Latin American, African, and Asian travelers were [15816 (0.09 [0.07-0.11]), 42290 (0.06 [0.05-0.07]), and 27433 (0.07 [0.06-0.09])] respectively. We identified lower published rates of chronic diarrhea from Sub-Saharan Africa relative to [North Africa, South Central Asia, and Central America]. Persistent/chronic diarrhea ranked fourth as a syndromic diagnosis in all regions.
Persistent/Chronic diarrhea is a leading syndromic diagnosis in returning travelers across all regions. The 6% incidence [proportionate morbidity (PM) of 60] observed in over >300,000 global travelers is comparable to prior estimates. We identified lower published rates of chronic diarrhea from Sub-Saharan Africa relative to [North Africa, South Central Asia, and Central America]. comprises an appreciabile percentatge of travel-associated infectious mediated persistent/chronic diarrhea. There's a dearth of published data characterizing the incidence of specific enteropathogenic etiologies for persistent/chronic diarrhea in returning travelers.
旅行者腹泻是一种常见疾病,在为期2周的旅行后,高达50%的旅行者会受到影响。这些病例中有相当一部分会发展为持续性或慢性腹泻。我们总结了已发表的关于旅行者持续性/慢性腹泻的文献,以阐明目前对疾病发病率、病因和区域差异的认识。
我们使用以下检索词在1990年至2015年的电子数据库(Medline、Embase和Cochrane临床试验数据库)中进行检索:“慢性或持续性腹泻和(返程)旅行者或肠道病原体、地理哨兵和旅行相关感染”。纳入以英文发表的关于成年返程旅行者(旅行时长<3个月)且报告分母数据的研究。使用随机效应模型计算发病率的点估计值和标准95%置信区间。使用异质性统计评估研究发病率的异质性率,并用森林图进行图形展示。
我们确定了19项符合纳入标准的研究(均在1999年之后发表)。18项研究报告了返程旅行者中持续性/慢性腹泻作为综合征诊断的发病率;一项研究报告了可用于评估病原体特异性病因的足够分母数据。在返程旅行者中,[某种病原体]占感染介导的持续性/慢性腹泻的相当比例。在321454名旅行者中,持续性/慢性腹泻的总体发病率估计为6%(0.05 - 0.07);各地区间存在显著异质性。拉丁美洲、非洲和亚洲旅行者的区域旅行者总数以及发病率的点估计值(95%置信区间)分别为[15816(0.09 [0.07 - 0.11])、42290(0.06 [0.05 - 0.07])和27433(0.07 [0.06 - 0.09])]。我们发现,与[北非、中亚南部和中美洲]相比,撒哈拉以南非洲地区公布的慢性腹泻发病率较低。在所有地区,持续性/慢性腹泻作为综合征诊断排名第四。
持续性/慢性腹泻是所有地区返程旅行者中主要的综合征诊断。在超过30万全球旅行者中观察到的6%发病率[发病比例(PM)为60]与先前估计值相当。我们发现,与[北非、中亚南部和中美洲]相比,撒哈拉以南非洲地区公布的慢性腹泻发病率较低。[某种病原体]占旅行相关感染介导的持续性/慢性腹泻的相当比例。缺乏已发表的数据来描述返程旅行者中持续性/慢性腹泻特定肠道致病病因的发病率。